Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-24,357
Closed -$405K – 1123
2021
Q4
$405K Hold
24,357
– – ﹤0.01% 996
2021
Q3
$372K Hold
24,357
– – ﹤0.01% 970
2021
Q2
$346K Sell
24,357
-5,538
-19% -$77.7K ﹤0.01% 850
2021
Q1
$376K Buy
29,895
+250
+0.8% +$2.72K ﹤0.01% 924
2020
Q4
$260K Sell
29,645
-631
-2% -$4.12K ﹤0.01% 899
2020
Q3
$224K Sell
30,276
-6,056
-17% -$39.7K ﹤0.01% 890
2020
Q2
$204K Hold
36,332
– – ﹤0.01% 937
2020
Q1
$129K Sell
36,332
-16,200
-31% -$112K ﹤0.01% 924
2019
Q4
$454K Hold
52,532
– – ﹤0.01% 926
2019
Q3
$456K Buy
52,532
+26,282
+100% +$226K ﹤0.01% 766
2019
Q2
$267K Hold
26,250
– – ﹤0.01% 779
2019
Q1
$277K Buy
+26,250
New +$264K ﹤0.01% 737

Aviva's VEDL Position: Q1 2022 in Review

Aviva sold out of Vedanta (VEDL) in Q1 2022, closing a stake of 24,357 shares — an estimated $405K sold.

Aviva first reported a position in VEDL in Q1 2019 and held it in 12 quarters. The position peaked at $456K in Q3 2019. 0 funds tracked by Wall St. Rank hold VEDL as of Q1 2022.

  • Aviva reported no remaining Vedanta position as of Q1 2022 after selling out during the quarter.
  • Aviva sold 24,357 Vedanta shares in Q1 2022, an estimated $405K.
  • Aviva first reported a position in Vedanta in Q1 2019 and held it in 12 quarters.
  • Aviva's Vedanta position peaked at $456K in Q3 2019.
  • 0 funds tracked by Wall St. Rank held Vedanta as of Q1 2022.

Based on Aviva's 13F filing for Q1 2022, filed 13 May 2022.